UKISFE

The Institute for the Study of Free Enterprise is dedicated to understanding the role that markets play in the economy and in society.

[UKISFE @UKISFE]

New publication by ISFE director @Courtemanche_CJ

[Charles Courtemanche, PhD @Courtemanche_CJ]

My paper with Joseph Garuccio reviewing the existing literature on the 340B drug discounting program has been published in the Journal of Economic Surveys: https://t.co/kkJwQ7VLgS

[UKISFE @UKISFE]

A new study by @Courtemanche_CJ and Joseph Garuccio reviews the literature on the impacts of Certificate-of-Need laws.
Read it on our website:
https://t.co/1rjk74IRUP

[NBER @nberpubs]

Despite the well-known weight gain from nicotine cessation, e-cigarette taxes do not contribute to obesity and may even decrease it, from @Courtemanche_CJ, Tessie Krishna, @YangLiangEcon, @SDSUCHEPS, and Anthony Chuo https://t.co/zIKGV7apFp

[UKISFE @UKISFE]

A new working paper by @Courtemanche_CJ, @tessie_krishna, @YangLiangEcon, Joseph J. Sabia, and @chuonomics examines the effect of e-cigarette taxation on obesity.
Read it on our website:
https://t.co/3p4hAkjmVx

[UKISFE @UKISFE]

This paper was released as ISFE Working Paper No. 60
Read it on our website:
https://t.co/X4OcJWTJyt

[UKISFE @UKISFE]

340B Report (@340B_Report) featured the 340B Drug Pricing Program working paper by ISFE's Charles Courtemanche (@Courtemanche_CJ) and Joseph Garuccio.
https://t.co/Qw8NHm3dlm

[UKISFE @UKISFE]

Congratulations to Chad Cotti, @Courtemanche_CJ, @YangLiangEcon, @JCMecon, @ErikNesson, and Joseph J. Sabia on their paper being accepted for publication in @JHealthEcon!
This paper was previously released as ISFE Working Paper No. 55
https://t.co/lPy73Rb61E

[UKISFE @UKISFE]

The new ISFE working paper by Michael E. Darden, @reginaldbhebert, @mikepesko, and @samuel_m_sturm uncovers important unintended consequences of cigarette taxes, particularly for low-income individuals.
Read it on our website:
https://t.co/ogqvkgBxE8

[UKISFE @UKISFE]

The views expressed here are those of the authors only, and do not represent the views of the Institute for the Study of Free Enterprise, Gatton College, or UK.

[UKISFE @UKISFE]

Senate Bill 14 in the Kentucky legislative session involves the federal 340B program, which bolsters the health care safety net without taxpayer money. This is a fascinating program that economists should pay more attention to!

[UKISFE @UKISFE]

We also discuss 340B’s legislative history. Drug companies agreed to expand the program in return for other policies that benefitted them: more business through Part D and the ACA as well as prohibitions on importing low-cost drugs and the government negotiating drug prices.